Patents by Inventor Toshio Onoda

Toshio Onoda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Piperidinylpyrazolopyridine derivative
    Patent number: 9150575
    Abstract: A compound represented by the general formula (I) or a pharmacologically acceptable salt thereof has an excellent LCAT-activating effect and is useful as an active ingredient in a therapeutic or prophylactic agent for arteriosclerosis, arteriosclerotic heart disease, coronary heart disease (including heart failure, myocardial infarction, angina pectoris, cardiac ischemia, cardiovascular disturbance, and restenosis caused by angiogenesis), cerebrovascular disease (including stroke and cerebral infarction), peripheral vascular disease (including diabetic vascular complications), dyslipidemia, hypo-HDL-cholesterolemia, or renal disease, particularly, an anti-arteriosclerotic agent, wherein R is an optionally substituted aryl group or an optionally substituted heteroaryl group.
    Type: Grant
    Filed: December 10, 2014
    Date of Patent: October 6, 2015
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Hideki Kobayashi, Nobuyuki Ohkawa, Daisuke Takano, Hideki Kubota, Toshio Onoda, Toshio Kaneko, Masami Arai, Naoki Terasaka
  • PIPERIDINYLPYRAZOLOPYRIDINE DERIVATIVE
    Publication number: 20150152102
    Abstract: A compound represented by the general formula (I) or a pharmacologically acceptable salt thereof has an excellent LCAT-activating effect and is useful as an active ingredient in a therapeutic or prophylactic agent for arteriosclerosis, arteriosclerotic heart disease, coronary heart disease (including heart failure, myocardial infarction, angina pectoris, cardiac ischemia, cardiovascular disturbance, and restenosis caused by angiogenesis), cerebrovascular disease (including stroke and cerebral infarction), peripheral vascular disease (including diabetic vascular complications), dyslipidemia, hypo-HDL-cholesterolemia, or renal disease, particularly, an anti-arteriosclerotic agent, wherein R is an optionally substituted aryl group or an optionally substituted heteroaryl group.
    Type: Application
    Filed: December 10, 2014
    Publication date: June 4, 2015
    Applicant: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Hideki Kobayashi, Nobuyuki Ohkawa, Daisuke Takano, Hideki Kubota, Toshio Onoda, Toshio Kaneko, Masami Arai, Naoki Terasaka